person

Hanno L.

Country
Germany
Department
n/a

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
113
Sites with multiple studies

Has run more than one trial at 113 of 147 partner sites.

Specializations

Pulmonary Vascular Research

The investigator specializes in pulmonary arterial hypertension (PAH) treatment approaches, with particular emphasis on innovative therapeutic interventions. Their research encompasses the evaluation of novel compounds for PAH management, including both oral and inhaled formulations.

  • Inhaled therapeutic solutions
  • Long-term safety assessments
  • Treatment of high-risk PAH patients

Their work includes investigating therapeutic options for patients across different PAH risk categories.

Advanced Cardiac Care

The investigator focuses on treating complex cardiovascular conditions, particularly combined postcapillary and precapillary pulmonary hypertension. Their research extends to patients with heart failure with preserved ejection fraction (HFpEF).

  • Pulmonary vascular resistance management
  • Exercise capacity improvement
  • Background therapy optimization

Their expertise includes evaluating interventions for complex cardiopulmonary conditions.

Clinical Outcomes Research

The investigator studies long-term therapeutic outcomes in pulmonary vascular disease, with particular attention to mortality risk reduction and quality of life improvements.

  • Disease progression monitoring
  • Treatment tolerability assessment
  • Extended follow-up studies

Their research includes evaluating therapeutic interventions for newly diagnosed and treatment-experienced patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.